Latest filing published 19 Nov 2024 for GeneDx Holdings Corp., €8.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -75.6%Entry US$15.35 · Close at T+365 US$3.74
- -89.1%Entry US$80.85 · Close at T+365 US$8.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
School of Medicine At Mount Sinai Icahn: trading record in brief
School of Medicine At Mount Sinai Icahn is a declared insider at 2 companies; the most frequent names are GeneDx Holdings Corp. and Renalytix plc. Between 29 April 2022 and 18 November 2024, the trades on record add up to 7 filings.
Both buying and selling appear: 2 purchases worth €33.0M, against 3 sales worth €69.7M. Netting one side against the other leaves €36.6M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2024 alone, the filings show no purchases and 3 sales.
On 19 November 2024 came the latest disclosure, an open-market sale for €8.5M in GeneDx Holdings Corp. The last purchase on record was published on 2 February 2023, which is 1,376 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to School of Medicine At Mount Sinai Icahn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 126,782 shares@ US$70.7755Class A Common StockSEC:0000950170-24-128961:1
- 20,359 shares@ US$69.78061.9% of flowClass A Common StockSEC:0000950170-24-128961:0
- 13,366,750 shares@ US$0.11639.4% of flowOrdinary SharesSEC:0000950170-24-121609:0
- 865,800 shares@ US$75.0085.0% of flowClass A Common StockSEC:0000950170-24-120867:0
- 9,360,374 shares@ US$0.2560.6% of flowOrdinary SharesSEC:0000950172-24-000236:0
- 28,571,428 shares@ US$0.3513.1% of flowClass A Common StockSEC:0001209191-23-006400:0Canonical exit: 1 May 2023 (T+90)
- 6,250,000 shares@ US$4.00100.0% of flowClass A Common StockSEC:0001209191-22-027435:0Canonical exit: 28 Jul 2022 (T+90)
7 of 7 declarations
